Researcher biography

Peter Csurhes is an immunologist with a strong research track record in multiple sclerosis (MS) research within UQ that has spanned 30 years.

Together with Emeritus Professor Michael Pender, Peter's work in a number of preclinical research studies into the role that immunity to Epstein-Barr virus (EBV) plays in MS disease pathogenesis has translated to clinical trials testing of potentially ground-breaking new T cell immunotherapeutic treatments for progressive MS. Collaborative links between QIMR Berghofer, Royal Brisbane and Women's Hospital and commercial partners have been established and clinical trials are ongoing.

Peter has also been involved in studying the role of reactivity to autoantigens in MS and in diseases of the peripheral nervous system including Guillain-Barre syndrome and CIDP.

For several years he worked on the immunology of potential malaria vaccine candidates and also currently works part-time on research into EBV-related cancers within the QIMR-Berghofer Medical Research Institute.